Friday, 21 Sep 2018

PsA/SpA

Datesort ascending Type Title Save
06 Nov 2017 Social RT @japaoli19: Osteitis condensans ilii vs AxSpA. OCI-no erosions on CT/female sex/hlab27neg/nmlcrp. #ACR17 @RheumNow #1510 https://t.co/U…
06 Nov 2017 Social RT @japaoli19: Secukinumab meets T2T endpoints in PsA.Early onset did better. Should we measure in clinic? #ACR17 @RheumNow #622 https://t.…
05 Nov 2017 Social RT @doctorakerkar: AxSpA- Does obesity affect response to TNF blockers? #ACR17 #AnkylosingSpondylitis @RheumNow https://t.co/ubmQHTqdVq
05 Nov 2017 Social RT @doctorakerkar: Therapies to look forward to in #AnkylosingSpondylitis #ACR17 https://t.co/h9uZQ08wbD
05 Nov 2017 Social RT @doctorakerkar: The reason why Etoricoxib is preferred NSAID in #AnkylosingSpondylitis #ACR17 @RheumNow https://t.co/gbit47We7n
05 Nov 2017 Social RT @_connectedcare: 12% progression in 2yrs to AS from nrAxSpA #ACR17 @rheumnow https://t.co/QcFR8zzRXF
05 Nov 2017 Social RT @doctorakerkar: High CRP main predictor of progression of nrAxSpA to AS #ACR17 @RheumNow https://t.co/E84Wfj7B1e
05 Nov 2017 Social RT @_connectedcare: Another study discussing progression to AS. Slightly inflammatory last comment #ACR17 @rheumnow https://t.co/UMVZf1rKET
05 Nov 2017 Social RT @japaoli19: UST tops TNFi resolving enthesitis in a small sample of PsA pts. ECLIPSA #881 #ACR17 @RheumNow https://t.co/5AKRP473dD https…
05 Nov 2017 Social RT @DrPetryna: 53% risk of VTE and 62%DVT in AS comparing to general population. Confounders not measured #ACR17 #3S078 @RheumNow https://t…
05 Nov 2017 Social RT @japaoli19: Higher risk of VTE on patients hospitalized with SpA, comparable with that of malignancy>OA #879 #ACR2017 @RheumNow https://…
05 Nov 2017 Social RT @doctorakerkar: >90% PsA patients showed no radiologic progression at 12 months on Tofacitinib Desiree Van Der Heijde #880 #ACR17 @Rheu…
05 Nov 2017 Social RT @doctorakerkar: Higher prevalence of venous thrombosis in SpA admissions- Inflammation driven thrombosis & NSAIDs to blame? Dilli Poude…
05 Nov 2017 Social RT @japaoli19: #578 Of 10 Biomarkers, combo of 2 showed small value added in terms of rad.progression in AxSpA #ACR17 @RheumNow
05 Nov 2017 Social RT @japaoli19: Low dose CT detects more spinal progression vs xray in AS measured by ct syndesmophyte sc #582 #ACR17 @rheumnow https://t.…
05 Nov 2017 Social RT @KDAO2011: #ACR17 metaanalysis:Adding MTX to TNFi helps skin scores NOT joints in pts w/PsA @rheumnow #636 https://t.co/2vAQgnYZXp
05 Nov 2017 Social Mease et al shows consentyx inhibits xray progression in Future5 996 PsA trial w 24wk outcomes https://t.co/qJqMZMulhP
05 Nov 2017 News Novartis Features Secukinumab Data at ACR 17
04 Nov 2017 Social RT @isa75012: Secukinumab (IL17i) works even in SpA pts that do not respond to TnFi. But it also may cause worsening IBD symptoms. Use caut…
04 Nov 2017 Social RT @DrPetryna: GI mucosal associated invariant T (MAIT) cells detected in joints of patients w/AS. Expanding views of SpA #ACR17 Sunday pre…